about
Mithramycin exerts an anti-myeloma effect and displays anti-angiogenic effects through up-regulation of anti-angiogenic factorsArgonaute 2 promotes myeloma angiogenesis via microRNA dysregulation.Macrophages in multiple myeloma: emerging concepts and therapeutic implications.Exosomal miR-135b shed from hypoxic multiple myeloma cells enhances angiogenesis by targeting factor-inhibiting HIF-1.Granulocytic myeloid-derived suppressor cells promote angiogenesis in the context of multiple myeloma.Molecular mechanisms, current management and next generation therapy in myeloma bone disease.Alantolactone induces G1 phase arrest and apoptosis of multiple myeloma cells and overcomes bortezomib resistance.Inhibition of mTOR with everolimus and silencing by vascular endothelial cell growth factor-specific siRNA induces synergistic antitumor activity in multiple myeloma cells.A peculiar molecular profile of umbilical cord-mesenchymal stromal cells drives their inhibitory effects on multiple myeloma cell growth and tumor progressionThe antibiotic chloramphenicol may be an effective new agent for inhibiting the growth of multiple myeloma.A First Report on [18F]FPRGD2 PET/CT Imaging in Multiple Myeloma.The relationship between soluble receptor of interleukin-6 with angiogenic cytokines and proliferation markers in multiple myeloma.Nonmyelomatous Ascites Resulting from the Increased Secretion of Vascular Endothelial Growth Factor in Multiple Myeloma.Endothelial progenitor cells in multiple myeloma neovascularization: a brick to the wall.Immunohistochemical expression of endoglin offers a reliable estimation of bone marrow neoangiogenesis in multiple myeloma.Increased serum levels of MIP-1alpha correlate with bone disease and angiogenic cytokines in patients with multiple myeloma.
P2860
Q28487743-3DDCC4E8-DEAB-4371-B5D4-806267B50C92Q33939162-9719294F-C554-415A-8339-1287C0933A0FQ34329242-0242FDE9-F2FC-4200-8944-E1AC63D5695BQ34683987-F052BDE6-EB32-40A6-8490-524EA7254B74Q37437357-FE024504-7222-4EAB-973D-66BBC39B5A5CQ38749233-A0A66AC3-CBC7-44FD-99F0-294FE51603A4Q38868587-42BE3628-7F6D-4267-B227-1D293C945A2DQ38987856-D2E5630B-D332-4A0F-B136-FE72E708FF9CQ39030703-33F7E374-260C-4145-946D-0B444D3FAF97Q42134172-2BB1E2DE-67A7-4754-932B-6F0B2850C55BQ43376041-0737F8E8-33A8-4F8B-99BA-070389A8B967Q44585463-A5FAEE5B-0B23-4B49-9B08-B404717AAD0CQ49901829-ECC61FA7-6E0B-422B-A7D1-BA33F1968A3EQ52535430-E00702E0-72A7-43E0-9655-DD9EC6126EA4Q53583112-722BE88E-FDCB-487A-8CBF-FBC2BEFE85C4Q54535110-215F90BF-5270-465E-9FFC-A8E33743F6D7
P2860
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Biological aspects of angiogenesis in multiple myeloma.
@en
Biological aspects of angiogenesis in multiple myeloma.
@nl
type
label
Biological aspects of angiogenesis in multiple myeloma.
@en
Biological aspects of angiogenesis in multiple myeloma.
@nl
prefLabel
Biological aspects of angiogenesis in multiple myeloma.
@en
Biological aspects of angiogenesis in multiple myeloma.
@nl
P2093
P2860
P50
P1476
Biological aspects of angiogenesis in multiple myeloma
@en
P2093
Eléonore Otjacques
Marilène Binsfeld
Yves Beguin
P2860
P2888
P304
P356
10.1007/S12185-011-0963-Z
P577
2011-11-17T00:00:00Z